About 1 result found for searched term "ABBV-744" (0.153 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M9218 | ABBV-744 | Epigenetic Reader Domain |
| ABBV-744 is a first-in-class, orally active and selective inhibitor of the BDII domain of the BET family of proteins with IC50 values of 4-18 nM for BRD2, BRD3, BRD4, and BRDT for AML and metastatic desmoplasia-resistant prostate cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
